A. Narayan

发表

SCHEMA: A general framework for integrating heterogeneous single-cell modalities

B. Berger, Rohit Singh, B. Hie, 2019, bioRxiv.

Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis.

Christopher B. Cooper, Amit K. Gupta, D. Murray, 2017, Journal of medicinal chemistry.

Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway

Amit K. Gupta, G. Balakrishnan, A. Narayan, 2016 .

C-reactive protein in HIV-infected patients--could it be a marker of immunosuppression?

S. Solomon, A. Narayan, S. Solomon, 2007, Clinica chimica acta; international journal of clinical chemistry.

UDP-N-Acetylmuramic Acid l-Alanine Ligase (MurC) Inhibition in a tolC Mutant Escherichia coli Strain Leads to Cell Death

A. Narayan, V. Ramachandran, Vaishali Humnabadkar, 2014, Antimicrobial Agents and Chemotherapy.

LC-MS based assay to measure intracellular compound levels in Mycobacterium smegmatis: linking compound levels to cellular potency.

A. Narayan, J. Bhat, M. Chatterji, 2013, Journal of microbiological methods.

Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.

A. Narayan, V. Ramachandran, R. Mclaughlin, 2014, Journal of medicinal chemistry.

Synthetic analogues of the parasitic worm product ES-62 reduce disease development in in vivo models of lung fibrosis.

Fraser J. Scott, M. Harnett, W. Harnett, 2018, Acta tropica.

Evidentiary value and effects of contaminants on blood group factors in medico

A. Narayan, 2015 .

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

J. Mckinney, L. Chiarelli, N. Dhar, 2014, Journal of medicinal chemistry.

Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.

A. Narayan, V. Ramachandran, V. Sambandamurthy, 2014, Journal of medicinal chemistry.

Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.

Vijay T. Ahuja, A. Srivastava, A. Narayan, 2013, Journal of medicinal chemistry.

Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

Christopher B. Cooper, S. Butler, A. Narayan, 2019, ACS medicinal chemistry letters.

2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis.

G. Balakrishnan, A. Narayan, V. Ramachandran, 2014, ACS medicinal chemistry letters.

Whole cell screen based identification of spiropiperidines with potent antitubercular properties.

Vasanthi Ramachandran, Riccardo Manganelli, S. Cole, 2015, Bioorganic & medicinal chemistry letters.

Comparison of counter current immunoelectrophoresis and Widal tests in the diagnosis of typhoid fever in childhood.

A. Narayan, V. Srivastava, L. Srivastava, 1986, Indian journal of pathology & microbiology.